There is much evidence which suggests that changes in the composition of gut microbiota may affect the host’s energy homeostasis, systemic inflammation, lipid metabolism, and insulin sensitivity in obesity and obesity-associated disorders, such as T2DM [40]. This evidence concerns the gene INS and type 2 diabetes mellitus.